We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | 0.06% | 1,819.00 | 1,819.00 | 1,821.00 | 1,832.00 | 1,813.00 | 1,825.00 | 396,909 | 16:35:16 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 20.96 | 4.02B |
From Apr 2019 to Apr 2024
TIDMHIK
RNS Number : 8326Q
FTSE Russell
23 June 2020
Hikma Pharmaceuticals (UK): Shares in Issue and Investability Weight Change
Changes in FTSE UK Index Series
23 June 2020
Hot Features
Premium
Following the receipt of updated shareholder information for Hikma Pharmaceuticals, (UK, constituent)
as a result of a secondary placing and concurrent share repurchase, please see details of
affected indexes and effective dates below:
Index Effective From
Start of Trading
FTSE 100 Index 26 June 2020
FTSE 350 Index 26 June 2020
------------------
FTSE All-Share Index 26 June 2020
------------------
FTSE 350 Lower Yield Index 26 June 2020
------------------
* The change to Index shares reflects the secondary placing only.
For further information please contact FTSE Russell Client Services at info@ftserussell.com
or call: Australia +1800 653 680
Hong Kong +852 2164 3333
Japan +81 3 4563 6346
London +44 (0) 20 7866 1810
New York +1866 551 0617
Alternatively please visit our website at www.ftserussell.com
Terms of Use | Copyright (c) 2020 FTSE Russell
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
FTSSEMFDDESSEIM
(END) Dow Jones Newswires
June 23, 2020 12:30 ET (16:30 GMT)
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
